((Director: Assaf Kozin, Video: Tal Shahar, Video Editor: Coral Coot Market))
“In developed countries such as Israel, Europe and the Far East, there is a transient deficiency and an accidental deficiency,” Gargier said. “In the least advanced countries and regions, there is a great shortage, and many people die from blood or insufficient blood that is not according to the correct standards.”
The process begins with stem cells, which can be divided and expanded indefinitely under the appropriate conditions. “If they get the right sermon and the right signals, they can become every type of cell in the body,” Gargre explained. “The vision is that one day we will produce in very large vital reactions, and thousands of liters simultaneously. Each of these ships will produce hundreds of blood units, which will be harvested, tested, their families and sent to hospitals around the world.”
The main scientist of the company, Dr. Orn Eslorberg Yiva, a specialist in stem cell transplantation, said the project immediately directed him. “I read about the company and I saw that it is something interested in me.” “This is something I can contribute to my knowledge.”
For GARGIR, the task is personal. He recalls, “Thirty -five years ago, when I was a student of biology, I went to umbrellas, shattered and lost a lot of blood.” “The transmission of blood like this saved my life.”
He said technology could save millions. “You will not need any donor. You will have one blood type that can suit everyone,” said Gargier. “About 2 million people dies all over the world from blood loss every year. If we can provide blood everywhere and every time, we can save many of those lives.”
Inside the RDC laboratory, stem cells are stored at temperatures less than 150 ° C. When melting and cultivating, each visible point is on one cell culture plate that grows into millions. “The capabilities are countless,” said inzelberg yifa.
RDC BIOTECH is now increasing its operations, with plans to advance towards before clinical and clinical trials and eventually a large -scale manufacturing. The company imagines factories all over the world that produces comprehensive red blood cells under local regulations to ensure reliable arrival in the most affected areas.